1220696-53-6

Basic information

• Product Name: 1,3-DIMETHYLINDAZOLE-5-BORONIC ACID PINACOL ESTER
• Synonyms: 1,3-DIMETHYLINDAZOLE-5-BORONIC ACID PINACOL ESTER;1,3-diMethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole
• CAS NO: 1220696-53-6
• Molecular Formula: C₁₅H₂₁BN₂O₂
• Molecular Weight: 272.15044
• EINECS: -0
• Mol File: 1220696-53-6.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,3-DIMETHYLINDAZOLE-5-BORONIC ACID PINACOL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-DIMETHYLINDAZOLE-5-BORONIC ACID PINACOL ESTER(1220696-53-6)
• EPA Substance Registry System: 1,3-DIMETHYLINDAZOLE-5-BORONIC ACID PINACOL ESTER(1220696-53-6)

Safety Data

• Hazardous Substances Data: 1220696-53-6(Hazardous Substances Data)

Usage

Uses

1,3-Dimethylindazole-5-boronic acid, pinacol ester

Upstream product

• 198477-89-3 1-(5-bromo-2-fluorophenyl)ethan-1-one 
• 76-09-5 2,3-dimethyl-2,3-butane diol 
• 1245816-25-4 (3-methyl-1H-indazol-5-yl)boronic acid 
• 864771-17-5 3-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-indazole 
• 74-88-4 methyl iodide 
• 552331-30-3 5-bromo-1,3-dimethyl-1H-indazole 
• 73183-34-3 bis(pinacol)diborane 
• 552331-16-5 5-bromo-3-methyl-1H-indazole 

Relevant articles and documents

HETEROAROMATIC COMPOUNDS USEFUL IN THERAPY

A compound of formula (I) useful in the treatment of a Pneumoviridae viral infection.

CONDENSED PYRIMIDINE OR PYRIDAZINE DERIVATIVES AS ANTIVIRAL AGENTS

A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is a prodrug of a PI4KIIIβinhibitor and as such is useful as an antiviral agent. A pharmaceutical composition comprising the compound.

FUSED PYRAZOLE DERIVATIVES AS KINASE INHIBITORS

A series of substituted pyrazolo[1,5-a]pyrimidine and pyrazolo[1,5-a][1,3,5]- triazine derivatives of formula (I), as defined herein, being selective inhibitors of phosphatidylinositol-4-kinase ΙΙΙβ (ΡI4ΚΙΙΙβ) activity, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and organ and cell transplant rejection.